 | Up a level |
Kvasnicka, H. M., Thiele, J., Bueso-Ramos, C. E., Hasserjian, R. P., Gianelli, U., Van der Walt, J., Molina, T. J. and Orazi, A. (2014). Criteria for Therapy Response and Progression in Patients with Myelofibrosis Based on Bone Marrow Features. The International European LeukemiaNet Consensus Project. Lab. Invest., 94. S. 357A - 358. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0307
Kvasnicka, H. M., Thiele, J., Bueso-Ramos, C. E., Hasserjian, R. P., Gianelli, U., Van der Walt, J., Molina, T. J. and Orazi, A. (2014). Criteria for Therapy Response and Progression in Patients with Myelofibrosis Based on Bone Marrow Features. The International European LeukemiaNet Consensus Project. Mod. Pathol., 27. S. 357A - 358. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0285
Kvasnicka, H. M., Thiele, J., Bueso-Ramos, C. E., Sun, W., Cortes, J., Kantarjian, H. M. and Verstovsek, S. (2014). CHANGES IN BONE MARROW MORPHOLOGY IN PATIENTS WITH MYELOFIBROSIS TREATED FOR UP TO 5 YEARS WITH EITHER RUXOLITINIB OR BEST AVAILABLE THERAPY. Haematologica, 99. S. 127 - 129. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078